Arisaph Pharmaceuticals

Arisaph Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing therapies for cancer, cardiovascular diseases, and diabetes. Its products include dipeptidyl peptidase IV inhibitors, stable GLP-1 agonists, HDL modulators, plaque reducers, and tumor-activated prodrugs.